To view this email as a web page, click here.
 
Afib 2019 Guidelines Update: 5 Questions
Evidence-based revisions to the AHA/ACC/HRS guidelines will affect management of your patients with atrial fibrillation. Do you know how? Find out with a quick quiz.
Read more
 
Optimal Treatment for Complex Afib Cases Excludes Aspirin
Atrial fibrillation patients at risk for ACS, stroke, and blood clots have better outcomes with an antithrombotic regimen of apixaban without aspirin, researchers report.
Read more
 
PLUS: NEWS ON THE ROLE OF hsCRP AND TESTSOTERONE IN CV EVENTS
 
Elevated hsCRP Tied to Poor Outcomes after ACS
High Endogenous Testosterone Ups Risk for Serious CV Events in Men
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.